White label ELPA - ClinicalTrials.eu

Study on the Effectiveness and Safety of Rozanolixizumab for Adults with Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOG-AD)

Not recruiting

3 1 1
Investigated Drugs:
- Rozanolixizumab
+4
Study Comparing Teclistamab, Talquetamab, and Drug Combination for Patients with Newly Diagnosed Multiple Myeloma Not Suitable for Stem Cell Transplant

Not recruiting

3 1 1 1
Investigated Drugs:
+8
Study of petosemtamab with pembrolizumab compared to pembrolizumab alone in patients with head and neck cancer who have not received previous treatment for advanced disease

Not recruiting

3 1 1 1
Investigated Drugs:
- Petosemtamab
- Pembrolizumab
+8
Study of ICT01 and Pembrolizumab for Patients with Advanced-Stage, Relapsed/Refractory Cancer

Not recruiting

2 1 1 1
Investigated Diseases:
- Haematological malignancy
- Neoplasm malignant
Investigated Drugs:
- Ict01
- Pembrolizumab
Study on the Safety and Tolerability of Exidavnemab in Patients with Mild to Moderate Parkinson’s Disease

Not recruiting

2 1
Investigated Diseases:
- Multiple system atrophy
- Parkinson’s disease
Investigated Drugs:
- Exidavnemab
Study on INZ-701 for Improving Survival in Infants with ENPP1 Deficiency

Not recruiting

3 1 1
Investigated Diseases:
- Ectonucleotide pyrophosphatase/phosphodiesterase 1 deficiency
Investigated Drugs:
- Recombinant Human Ectonucleotide Pyrophosphatase/Phosphodiesterase 1 Fused To The Fc Fragment Of Igg1
Study of Zanidatamab and Tislelizumab Combined with Chemotherapy for Patients with Advanced or Metastatic HER2-positive Gastroesophageal Cancer

Not recruiting

3 1 1 1
Investigated Diseases:
- Gastric cancer
- Oesophageal adenocarcinoma
Investigated Drugs:
+6
Study of Tazemetostat with R-CHOP for Newly Diagnosed Diffuse Large B Cell Lymphoma or High-Risk Follicular Lymphoma Patients

Not recruiting

2 1 1 1
Investigated Diseases:
- Diffuse large B-cell lymphoma
- Follicular lymphoma
Investigated Drugs:
Trial of Ataluren for Severe Common Variable Immunodeficiency with Autoimmunity in Patients with LRBA Deficiency

Not recruiting

2 1 1 1
Investigated Drugs:
- Ataluren
Study of NIDO-361 for Patients with Spinal and Bulbar Muscular Atrophy (SBMA)

Not recruiting

2 1
Investigated Diseases:
- Bulbospinal muscular atrophy congenital
Investigated Drugs:
- Nido-361

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies